The Filings Report

DuPont de Nemours, Inc. Common Stock

DDNYSECIK 1666700Basic Materials / Chemicalsfiscal year ends December43 quarters since 2015

Revenue, Q2 FY2026
$1.8B
+4.0% on Q2 FY2025
Net income
$143M
+142.4% on Q2 FY2025
Free cash flow
—
no year-earlier figure
Diluted EPS
$1.05
+150.0% on Q2 FY2025
Revenue, TTM
$7.0B
trailing four quarters
Net margin, TTM
0.8%
net income $55M
Free cash flow, TTM
—
Cash and equivalents
$1.7B
long-term debt —, Jun 30, 2026
Shares, 12-month change
−59.5%
135M shares, Jun 30, 2026
Buybacks, TTM
—
no yield
Dividends, TTM
$417M
2.2% of market value
Market value
$18.9B
at the close, buybacks

Latest quarter Q2 FY2026, filed August 4, 2026. Trailing figures sum the latest four quarters. Market values at the latest close, from a market data vendor.

In Q2 FY2026, the quarter ended June 30, 2026, DuPont de Nemours, Inc. Common Stock reported revenue of $1.8B, +4.0% on Q2 FY2025, and net income of $143M (+142.4%). Diluted earnings per share were $1.05.

The last 16 quarters

Q3 FY2022 to Q2 FY2026, through the filing of August 4, 2026.

Revenue and net incomeRevenueNet income
−$4B−$2B$0$2B$4B$6BQ3'22, Revenue: $3.3BQ3'22, Net income: $367MQ3'22Q4'22, Revenue: $3.1BQ4'22, Net income: $4.2BQ4'22Q1'23, Revenue: $3.0BQ1'23, Net income: $257MQ1'23Q2'23, Revenue: $3.1BQ2'23, Net income: −$131MQ2'23Q3'23, Revenue: $3.1BQ3'23, Net income: $319MQ3'23Q4'23, Revenue: −$2.6BQ4'23, Net income: −$22MQ4'23Q1'24, Revenue: $1.6BQ1'24, Net income: $188MQ1'24Q2'24, Revenue: $1.7BQ2'24, Net income: $178MQ2'24Q3'24, Revenue: $1.7BQ3'24, Net income: $454MQ3'24Q4'24, Revenue: $1.7BQ4'24, Net income: −$117MQ4'24Q1'25, Revenue: $1.6BQ1'25, Net income: −$589MQ1'25Q2'25, Revenue: $1.7BQ2'25, Net income: $59MQ2'25Q3'25, Revenue: $1.8BQ3'25, Net income: −$123MQ3'25Q4'25, Revenue: $1.7BQ4'25, Net income: −$126MQ4'25Q1'26, Revenue: $1.7BQ1'26, Net income: $161MQ1'26Q2'26, Revenue: $1.8BQ2'26, Net income: $143MQ2'26−$4B−$2B$0$2B$4B$6BQ3'22, Revenue: $3.3BQ3'22, Net income: $367MQ4'22, Revenue: $3.1BQ4'22, Net income: $4.2BQ4'22Q1'23, Revenue: $3.0BQ1'23, Net income: $257MQ2'23, Revenue: $3.1BQ2'23, Net income: −$131MQ2'23Q3'23, Revenue: $3.1BQ3'23, Net income: $319MQ4'23, Revenue: −$2.6BQ4'23, Net income: −$22MQ4'23Q1'24, Revenue: $1.6BQ1'24, Net income: $188MQ2'24, Revenue: $1.7BQ2'24, Net income: $178MQ2'24Q3'24, Revenue: $1.7BQ3'24, Net income: $454MQ4'24, Revenue: $1.7BQ4'24, Net income: −$117MQ4'24Q1'25, Revenue: $1.6BQ1'25, Net income: −$589MQ2'25, Revenue: $1.7BQ2'25, Net income: $59MQ2'25Q3'25, Revenue: $1.8BQ3'25, Net income: −$123MQ4'25, Revenue: $1.7BQ4'25, Net income: −$126MQ4'25Q1'26, Revenue: $1.7BQ1'26, Net income: $161MQ2'26, Revenue: $1.8BQ2'26, Net income: $143MQ2'26

Net income losses drawn in red.

Free cash flow
−$400M−$200M$0$200M$400MQ3'22, Free cash flow: $264MQ3'22Q4'22, Free cash flow: −$286MQ4'22Q1'23, Free cash flow: $111MQ1'23Q2'23Q3'23Q4'23Q1'24Q2'24Q3'24Q4'24Q1'25Q2'25Q3'25Q4'25Q1'26Q2'26−$400M−$200M$0$200M$400MQ3'22, Free cash flow: $264MQ4'22, Free cash flow: −$286MQ4'22Q1'23, Free cash flow: $111MQ2'23Q4'23Q2'24Q4'24Q2'25Q4'25Q2'26

Operating cash flow less capital expenditures; negative quarters in red.

Cash and equivalents against long-term debtCash and equivalentsLong-term debt
$0$5B$10B$15BQ3'22, Cash and equivalents: $1.8BQ3'22, Long-term debt: $10.6BQ3'22Q4'22, Cash and equivalents: $3.7BQ4'22, Long-term debt: $8.1BQ4'22Q1'23, Cash and equivalents: $3.5BQ1'23, Long-term debt: $8.1BQ1'23Q2'23, Cash and equivalents: $4.9BQ2'23, Long-term debt: $8.1BQ2'23Q3'23, Cash and equivalents: $1.3BQ3'23, Long-term debt: $8.2BQ3'23Q4'23, Cash and equivalents: $2.4BQ4'23, Long-term debt: $7.9BQ4'23Q1'24, Cash and equivalents: $1.9BQ1'24, Long-term debt: $7.9BQ1'24Q2'24, Cash and equivalents: $1.5BQ2'24, Long-term debt: $7.2BQ2'24Q3'24, Cash and equivalents: $1.6BQ3'24, Long-term debt: $7.2BQ3'24Q4'24, Cash and equivalents: $1.8BQ4'24Q1'25, Cash and equivalents: $1.8BQ1'25Q2'25, Cash and equivalents: $1.8BQ2'25Q3'25, Cash and equivalents: $2.0BQ3'25Q4'25, Cash and equivalents: $715MQ4'25Q1'26, Cash and equivalents: $710MQ1'26Q2'26, Cash and equivalents: $1.7BQ2'26$0$5B$10B$15BQ3'22, Cash and equivalents: $1.8BQ3'22, Long-term debt: $10.6BQ4'22, Cash and equivalents: $3.7BQ4'22, Long-term debt: $8.1BQ4'22Q1'23, Cash and equivalents: $3.5BQ1'23, Long-term debt: $8.1BQ2'23, Cash and equivalents: $4.9BQ2'23, Long-term debt: $8.1BQ2'23Q3'23, Cash and equivalents: $1.3BQ3'23, Long-term debt: $8.2BQ4'23, Cash and equivalents: $2.4BQ4'23, Long-term debt: $7.9BQ4'23Q1'24, Cash and equivalents: $1.9BQ1'24, Long-term debt: $7.9BQ2'24, Cash and equivalents: $1.5BQ2'24, Long-term debt: $7.2BQ2'24Q3'24, Cash and equivalents: $1.6BQ3'24, Long-term debt: $7.2BQ4'24, Cash and equivalents: $1.8BQ4'24Q1'25, Cash and equivalents: $1.8BQ2'25, Cash and equivalents: $1.8BQ2'25Q3'25, Cash and equivalents: $2.0BQ4'25, Cash and equivalents: $715MQ4'25Q1'26, Cash and equivalents: $710MQ2'26, Cash and equivalents: $1.7BQ2'26

Positions at each quarter end, as filed; short-term investments are not included.

Income statement

Last eight quarters, newest first, through Q2 FY2026 filed August 4, 2026.

DuPont de Nemours, Inc. Common Stock income statement, quarterly
Millions of dollarsQ2 FY2026ended Jun 30, 2026filed Aug 4, 2026Q1 FY2026ended Mar 31, 2026filed May 5, 2026Q4 FY2025ended Dec 31, 2025filed Feb 17, 2026Q3 FY2025ended Sep 30, 2025filed Nov 6, 2025Q2 FY2025ended Jun 30, 2025filed Aug 5, 2025Q1 FY2025ended Mar 31, 2025filed May 2, 2025Q4 FY2024ended Dec 31, 2024filed Feb 14, 2025Q3 FY2024ended Sep 30, 2024filed Nov 5, 2024YoYQ2 FY2026vs Q2 FY2025
Revenue1,8191,6811,6931,7951,7491,6121,6891,714+4.0%
Cost of revenue1,1801,0791,0951,1791,1431,0691,1361,134+3.2%
Gross profit—————————
Research and development4247withheldwithheldwithheldwithheld(167)127—
Selling, general and administrative269255withheldwithheldwithheldwithheldwithheldwithheld—
Operating income—————————
Other income (expense)4236(98)24(9)100(258)200+566.7%
Pretax income266181(66)917897(199)287+241.0%
Income tax7531withheldwithheldwithheldwithheld(75)99—
Net income143161(126)(123)59(589)(117)454+142.4%
Diluted EPS ($)1.051.17*(0.90)*(0.87)*0.42(4.20)*(0.84)*3.24*+150.0%
Diluted shares (millions)137138*—140*140140*—140*—

Fourth quarters are the fiscal year less the first nine months when the filer reports no discrete fourth quarter, and are marked. Diluted EPS is never derived, so a derived quarter shows none. Italic figures are derived.

Balance sheet

Last eight quarters, newest first, through Q2 FY2026 filed August 4, 2026.

DuPont de Nemours, Inc. Common Stock balance sheet, quarterly
Millions of dollarsQ2 FY2026ended Jun 30, 2026filed Aug 4, 2026Q1 FY2026ended Mar 31, 2026filed May 5, 2026Q4 FY2025ended Dec 31, 2025filed Feb 17, 2026Q3 FY2025ended Sep 30, 2025filed Nov 6, 2025Q2 FY2025ended Jun 30, 2025filed Aug 5, 2025Q1 FY2025ended Mar 31, 2025filed May 2, 2025Q4 FY2024ended Dec 31, 2024filed Feb 14, 2025Q3 FY2024ended Sep 30, 2024filed Nov 5, 2024YoYQ2 FY2026vs Q2 FY2025
Cash and equivalents1,7407107151,9551,8371,7621,7921,645−5.3%
Short-term investments—————————
Total current assets4,8565,6435,57510,0216,8506,46420,7756,439−29.1%
Total assets21,06121,44921,57538,04436,55935,98136,63637,461−42.4%
Total current liabilities2,0012,1032,3055,0054,8534,6325,4962,825−58.8%
Long-term debt———————7,170—
Total liabilities7,1807,2117,47214,70313,04312,71312,84312,804−45.0%
Stockholders’ equity13,76914,04013,91922,89423,06422,83423,35024,212−40.3%
Shares outstanding (millions)135137*136*140*334*333*333*333*—

Positions at each period end. Nothing on this statement is derived. Long-term debt is the filed noncurrent line only; no total-debt composite is constructed across filers. Italic figures are derived.

Cash flow statement

Last eight quarters, newest first, through Q2 FY2026 filed August 4, 2026.

DuPont de Nemours, Inc. Common Stock cash flow statement, quarterly
Millions of dollarsQ2 FY2026ended Jun 30, 2026filed Aug 4, 2026Q1 FY2026ended Mar 31, 2026filed May 5, 2026Q4 FY2025ended Dec 31, 2025filed Feb 17, 2026Q3 FY2025ended Sep 30, 2025filed Nov 6, 2025Q2 FY2025ended Jun 30, 2025filed Aug 5, 2025Q1 FY2025ended Mar 31, 2025filed May 2, 2025Q4 FY2024ended Dec 31, 2024filed Feb 14, 2025Q3 FY2024ended Sep 30, 2024filed Nov 5, 2024YoYQ2 FY2026vs Q2 FY2025
Operating cash flow—————————
Capital expenditures76102(150)31150122(91)67+52.0%
Free cash flow (CFO − capex)—————————
Depreciation and amortization154155withheldwithheldwithheldwithheldwithheldwithheld—
Share repurchases—————————
Dividends paid818282172171172159159−52.6%

10-Qs file cash flows as year-to-date totals, so quarterly figures are differenced from consecutive filings and marked. Free cash flow is operating cash flow less capital expenditures, computed from the two filed lines. Italic figures are derived.

Annual statements

Every fiscal year filed, newest first, through FY2025 filed February 17, 2026.

Income statement

DuPont de Nemours, Inc. Common Stock income statement, annual
Millions of dollarsFY2025ended Dec 31, 2025filed Feb 17, 2026FY2024ended Dec 31, 2024filed Feb 14, 2025FY2023ended Dec 31, 2023filed Feb 15, 2024FY2022ended Dec 31, 2022filed Feb 15, 2023FY2021ended Dec 31, 2021filed Feb 11, 2022FY2020ended Dec 31, 2020filed Feb 12, 2021FY2019ended Dec 31, 2019filed Feb 14, 2020FY2018ended Dec 31, 2018filed Feb 11, 2019FY2017ended Dec 31, 2017filed Feb 15, 2018FY2016ended Dec 31, 2016filed Nov 6, 2017FY2015ended Dec 31, 2015filed Nov 6, 2017
Revenue6,8496,7196,61413,01712,56611,12815,43622,59411,67248,15848,778
Cost of revenue4,4864,4994,4428,4027,9717,06310,02615,3029,55837,66837,745
Gross profit———————20,64412,69310,518—
Research and development1932031925365575656891,0706571,5931,598
Selling, general and administrative1,0199768911,4671,6021,4922,0573,0281,6152,9532,948
Operating income———————————
Other income (expense)14(111)8019114563214492661,4864,716
Pretax income200117(279)1,4481,444(1,259)(126)600(1,525)4,4139,930
Income tax102213(217)38723790(2)195(1,758)92,147
Net income(779)7034235,8686,467(2,951)4983,8451,1594,3187,685
Diluted EPS ($)(5.58)*5.04*2.82*14.75*14.92*(5.03)*0.84*6.23*2.70*13.26*23.16*
Diluted shares (millions)140*140*150*398*434*586*595*615*424*298*330*

Balance sheet

DuPont de Nemours, Inc. Common Stock balance sheet, annual
Millions of dollarsFY2025ended Dec 31, 2025filed Feb 17, 2026FY2024ended Dec 31, 2024filed Feb 14, 2025FY2023ended Dec 31, 2023filed Feb 15, 2024FY2022ended Dec 31, 2022filed Feb 15, 2023FY2021ended Dec 31, 2021filed Feb 11, 2022FY2020ended Dec 31, 2020filed Feb 12, 2021FY2019ended Dec 31, 2019filed Feb 14, 2020FY2018ended Dec 31, 2018filed Feb 11, 2019FY2017ended Dec 31, 2017filed Feb 15, 2018FY2016ended Dec 31, 2016filed Nov 6, 2017FY2015ended Dec 31, 2015filed Nov 6, 2017
Cash and equivalents7151,7922,3923,6621,9722,5441,5408,54813,4386,6078,577
Short-term investments——01,3020—0299560—
Total current assets5,57520,7757,51411,27014,30329,0089,999126,65550,06923,659—
Total assets21,57536,63638,55241,35545,70770,90369,349187,855192,41979,51167,938
Total current liabilities2,3055,4963,0983,7334,93112,2268,34673,31226,30412,604—
Long-term debt——7,8598,14510,63215,612(15,618)(12,635)32,12321,091—
Total liabilities7,47212,84313,82714,33818,65731,83427,79391,955———
Stockholders’ equity13,91923,35024,27926,56926,43338,50440,98794,292100,28925,987—
Shares outstanding (millions)136*333*333*365*409*429*589*599*618*——

Cash flow statement

DuPont de Nemours, Inc. Common Stock cash flow statement, annual
Millions of dollarsFY2025ended Dec 31, 2025filed Feb 17, 2026FY2024ended Dec 31, 2024filed Feb 14, 2025FY2023ended Dec 31, 2023filed Feb 15, 2024FY2022ended Dec 31, 2022filed Feb 15, 2023FY2021ended Dec 31, 2021filed Feb 11, 2022FY2020ended Dec 31, 2020filed Feb 12, 2021FY2019ended Dec 31, 2019filed Feb 14, 2020FY2018ended Dec 31, 2018filed Feb 11, 2019FY2017ended Dec 31, 2017filed Feb 15, 2018FY2016ended Dec 31, 2016filed Nov 6, 2017FY2015ended Dec 31, 2015filed Nov 6, 2017
Operating cash flow———5882,2814,0951,4094,731(765)(2,957)7,607
Capital expenditures3332853026627881,1942,4721,2445513,8043,703
Free cash flow (CFO − capex)———(74)1,4932,901(1,063)3,487(1,316)(6,761)3,904
Depreciation and amortization6476355801,1351,1123,0943,1952,1701,0602,8622,521
Share repurchases————2,1432322,3294,4211,0009161,166
Dividends paid5976356516526308821,6113,4913,3942,4622,253

Insider activity

Form 4 filings by officers, directors and 10% owners, November 1, 2024 to November 1, 2026. Only open-market purchases and sales count as buys and sells; awards, exercises, tax withholding and gifts are listed in grey and never counted.

Bought, three months
$0
0 purchases by 0 insiders; officers and directors $0
Sold, three months
$0
0 sales by 0 insiders; officers and directors $0
Bought, twelve months
$0
0 purchases by 0 insiders; officers and directors $0
Sold, twelve months
$607K
3 sales by 2 insiders; officers and directors $607K

The last 25 transactions

TradedInsiderRoleTransactionSharesPriceValueHeld afterFiled
Aug 28, 2026Macpherson Donald GDirectoraward237$136.98$33K2,196Sep 1, 2026
Aug 28, 2026Lowery Frederick M.Directoraward283$136.98$39K13,862Sep 1, 2026
Aug 28, 2026Cutler Alexander MDirectoraward365$136.98$50K25,155Sep 1, 2026
Aug 17, 2026Breen Edward DDirectorgift34,485$0.00—91,493Aug 19, 2026
Aug 6, 2026Ferreira BethPresident, Diversified Indstrltax withholding374$146.38$55K6,560Aug 10, 2026
Aug 6, 2026Barber Madeleine GVP Chief Accounting Officertax withholding101$146.38$15K1,793Aug 10, 2026
Jun 2, 2026Koch LoriCEO, Directoropen-market saleindirect261$48.82$13K0Jun 2, 2026
May 31, 2026Koch LoriCEO, Directortax withholding4,673$48.03$224K345,172Jun 2, 2026
May 31, 2026Franzen Antonella BSVP & CFOtax withholding1,558$48.03$75K68,809Jun 2, 2026
May 29, 2026Macpherson Donald GDirectoraward671$48.42$33K5,868Jun 2, 2026
May 29, 2026Lowery Frederick M.Directoraward800$48.42$39K40,205Jun 2, 2026
May 29, 2026Cutler Alexander MDirectoraward1,033$48.42$50K81,794Jun 2, 2026
May 21, 2026Macpherson Donald GDirectoraward4,030$0.00—5,197May 28, 2026
May 21, 2026Breen Edward DDirectoraward4,030$0.00—278,008May 28, 2026
May 21, 2026McMaken Kurt BDirectoraward4,030$0.00—8,258May 28, 2026
May 21, 2026Lowery Frederick M.Directoraward4,030$0.00—39,405May 28, 2026
May 21, 2026Lico James ADirectoraward4,030$0.00—10,839May 28, 2026
May 21, 2026du Pont Eleuthere IDirectoraward4,030$0.00—42,371May 28, 2026
May 21, 2026Cutler Alexander MDirectoraward4,030$0.00—80,762May 28, 2026
May 21, 2026Chandy Ruby RDirectoraward4,030$0.00—25,444May 28, 2026
May 21, 2026Brady Amy G.Directoraward4,030$0.00—23,781May 28, 2026
May 4, 2026Breen Edward DDirectortax withholding11,538$45.54$525K273,978May 6, 2026
May 4, 2026Franzen Antonella BSVP & CFOtax withholding246$45.54$11K70,367May 6, 2026
May 4, 2026Hoover Erik T.SVP & General Counseltax withholding1,526$45.54$69K115,972May 6, 2026
May 4, 2026Koch LoriCEO, Directortax withholding3,048$45.54$139K349,845May 6, 2026

Full insider history for DuPont de Nemours, Inc. Common Stock, or insider activity across all companies. A record of filings, not a recommendation.

Sources

Fiscal year ends in month 12; periods are labeled with the issuer's own fiscal calendar. Values are as most recently filed (restatements apply; per-share values are on current split basis per the connector's split table, flagged in adjusted). Flow items flagged in `derived` were computed (Q4 = FY − nine months; quarterly cash flow differenced from year-to-date filings) rather than read from a filing. `reconciliation.repaired` lists periods where a full-year figure was filed in a quarter slot: that row was dropped and the quarter rebuilt from the annual figure. `reconciliation.quarantined` lists periods where four filed quarters do not sum to the filed year — those quarterly values are withheld, so a blank there is a withholding rather than an absence of reporting.

Filer
DUPONT DE NEMOURS, INC., CIK 1666700 on EDGAR
Extract generated
November 1, 2026
Withheld
16 line-years whose four quarters do not sum to the filed year: net income FY2017, opex sga FY2018, other income FY2018, rnd FY2018, buybacks FY2019, cost of revenue FY2019, revenue FY2019, depreciation amortization FY2020, cost of revenue FY2020, revenue FY2020, depreciation amortization FY2024, opex sga FY2024, depreciation amortization FY2025, income tax FY2025, opex sga FY2025, rnd FY2025
Repaired
6 quarters where a full-year figure was filed in a quarter slot and the quarter was rebuilt: capex FY2017, cost of revenue FY2017, revenue FY2017, income tax FY2018, pretax income FY2018, income tax FY2020
XBRL concepts behind each line

Income statement

Revenue: RevenueFromContractWithCustomerExcludingAssessedTax, Revenues, SalesRevenueNet
Cost of revenue: CostOfGoodsAndServicesSold
Gross profit: GrossProfit
Research and development: ResearchAndDevelopmentExpense
Selling, general and administrative: SellingGeneralAndAdministrativeExpense
Operating income: not filed
Other income (expense): NonoperatingIncomeExpense
Pretax income: IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
Income tax: IncomeTaxExpenseBenefit
Net income: NetIncomeLoss
Diluted EPS ($): EarningsPerShareDiluted
Diluted shares (millions): WeightedAverageNumberOfDilutedSharesOutstanding

Balance sheet

Cash and equivalents: CashAndCashEquivalentsAtCarryingValue
Short-term investments: MarketableSecuritiesCurrent, ShortTermInvestments
Total current assets: AssetsCurrent
Total assets: Assets
Total current liabilities: LiabilitiesCurrent
Long-term debt: LongTermDebt
Total liabilities: Liabilities
Stockholders’ equity: StockholdersEquity
Shares outstanding (millions): dei:EntityCommonStockSharesOutstanding

Cash flow statement

Operating cash flow: NetCashProvidedByUsedInOperatingActivities
Capital expenditures: PaymentsToAcquireProductiveAssets
Free cash flow (CFO − capex): not filed
Depreciation and amortization: DepreciationDepletionAndAmortization
Share repurchases: PaymentsForRepurchaseOfCommonStock
Dividends paid: PaymentsOfDividends, PaymentsOfDividendsCommonStock

The data

The statements on this page as files, generated November 1, 2026.

JSON file
/data/financials/DD.json